TRENDSPOTTER: The View from Germany | GenomeWeb

GERMANY HAS taken a leading role in Europe’s genomics industry, and going forward the country’s contribution promises to grow. Market watchers expect some $200 million in public funds to be made available in the near future, demonstrating Germany’s commitment to staying at the forefront of innovative medical and scientific research.

All of this underscores one fundamental shift in the German mindset: People are no longer afraid of genomic and biomedical research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.